NanoViricides, Inc. Common Stock (NNVC)
1.1500
-0.0100 (-0.86%)
NYSE · Last Trade: Apr 3rd, 12:47 AM EDT

Via Benzinga · June 20, 2024

Via Benzinga · June 20, 2024

Via Benzinga · June 14, 2024

Via Benzinga · June 12, 2024

Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news affecting shares this morning!
Via InvestorPlace · June 6, 2024

Via Benzinga · June 5, 2024

Via Benzinga · June 4, 2024

Via Benzinga · June 3, 2024

NNVC stock results show that Nanoviricides beat analyst estimates for earnings per share the third quarter of 2024.
Via InvestorPlace · May 15, 2024

Discover three nanotech stocks poised for explosive growth in a booming market. Explore their potential for massive returns.
Via InvestorPlace · May 2, 2024

Colds, flu and RSV aren't the only viral illnesses people have to worry about this winter. A new variant of COVID-19 is rapidly spreading, reminding the world of just how dangerous this virus is.
Via Benzinga · January 31, 2024

NanoViricides, Inc. (NYSE American: NNVC) recently announced that it is presenting at Biotech Showcase™ 2024. Event Information: Event NanoViricides Presentation at the Biotech Showcase, San Fransisco
Via Benzinga · January 8, 2024
Is This Ticker That InvestorsObserver Expects To Soar By More Than 350% Next Year On Your Watchlist?
--News Direct--
Via News Direct · December 1, 2023

Read the latest report on NanoViricides here
Via Benzinga · October 2, 2023

Read the latest report on NanoViricides here
Via Benzinga · September 26, 2023

Via Benzinga · August 22, 2023

Read the latest report on NanoViricides here.
Via Benzinga · July 18, 2023

NanoViricides Inc (NYSE: NNVC) shares are trading higher after the company reported preclinical data from an antiviral clinical drug candidate for
Via Benzinga · July 11, 2023

Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?
Via News Direct · July 11, 2023

Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday.
Via Benzinga · July 11, 2023